Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Bruker Corp’s stock clocked out at $48.02, down -1.54% from its previous closing price of $48.77. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 1.46 million shares were traded. BRKR stock price reached its highest trading level at $48.45 during the session, while it also had its lowest trading level at $47.54.
Ratios:
To gain a deeper understanding of BRKR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
On December 09, 2025, Goldman started tracking the stock assigning a Sell rating and target price of $40. On November 20, 2025, Rothschild & Co Redburn started tracking the stock assigning a Buy rating and target price of $60.Rothschild & Co Redburn initiated its Buy rating on November 20, 2025, with a $60 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 01 ’25 when PACKER RICHARD A sold 5,028 shares for $48.38 per share. The transaction valued at 243,230 led to the insider holds 89,174 shares of the business.
RICHARD A PACKER bought 5,028 shares of BRKR for $243,230 on Dec 01 ’25. On Nov 06 ’25, another insider, ORNELL JOHN A, who serves as the Director of the company, sold 6,233 shares for $39.00 each. As a result, the insider received 243,087 and left with 35,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 7296214016 and an Enterprise Value of 9111113728. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 44.84. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.12 while its Price-to-Book (P/B) ratio in mrq is 2.99. Its current Enterprise Value per Revenue stands at 2.649 whereas that against EBITDA is 15.575.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.17, which has changed by -0.16360831 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $64.64, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 11.90%, while the 200-Day Moving Average is calculated to be 22.97%.
Shares Statistics:
It appears that BRKR traded 2.87M shares on average per day over the past three months and 2177550 shares per day over the past ten days. A total of 151.39M shares are outstanding, with a floating share count of 103.19M. Insiders hold about 32.08% of the company’s shares, while institutions hold 89.00% stake in the company. Shares short for BRKR as of 1764288000 were 13704909 with a Short Ratio of 4.77, compared to 1761868800 on 13850895. Therefore, it implies a Short% of Shares Outstanding of 13704909 and a Short% of Float of 19.42.
Dividends & Splits
With its trailing 12-month dividend rate of 0.2, BRKR has a forward annual dividend rate of 0.20. Against a Trailing Annual Dividend Yield of 0.0041008815. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
Its stock is currently analyzed by 13.0 different market analysts. The consensus estimate for the next quarter is $0.42, with high estimates of $0.61 and low estimates of $0.27.
Analysts are recommending an EPS of between $1.9 and $1.86 for the fiscal current year, implying an average EPS of $1.88. EPS for the following year is $2.15, with 15.0 analysts recommending between $2.44 and $2.0.
Revenue Estimates
In. The current quarter, 12 analysts expect revenue to total $958.3M. It ranges from a high estimate of $966.5M to a low estimate of $952.51M. As of. The current estimate, Bruker Corp’s year-ago sales were $979.6MFor the next quarter, 12 analysts are estimating revenue of $803.82M. There is a high estimate of $828.43M for the next quarter, whereas the lowest estimate is $770M.
A total of 13 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.43B, while the lowest revenue estimate was $3.41B, resulting in an average revenue estimate of $3.42B. In the same quarter a year ago, actual revenue was $3.37BBased on 13 analysts’ estimates, the company’s revenue will be $3.47B in the next fiscal year. The high estimate is $3.55B and the low estimate is $3.43B.
